0001613103-24-000133.txt : 20240816 0001613103-24-000133.hdr.sgml : 20240816 20240816070142 ACCESSION NUMBER: 0001613103-24-000133 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240621 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240816 DATE AS OF CHANGE: 20240816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 241214112 BUSINESS ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K/A 1 mdt-20240621.htm 8-K/A mdt-20240621
0001613103D02 XH02trueUpdating prior disclosure as a result of compensation committee approval of new compensation arrangements for our interim CFO.H91 VY1900016131032024-06-212024-06-210001613103dei:FormerAddressMember2024-06-212024-06-210001613103us-gaap:CommonStockMember2024-06-212024-06-210001613103mdt:A0.250SeniorNotesDue2025Member2024-06-212024-06-210001613103mdt:A0.000SeniorNotesDue2025Member2024-06-212024-06-210001613103mdt:A2.625SeniorNotesDue2025Member2024-06-212024-06-210001613103mdt:A1.125SeniorNotesDue2027Member2024-06-212024-06-210001613103mdt:A0.375SeniorNotesDue2028Member2024-06-212024-06-210001613103mdt:A3.000SeniorNotesDue2028Member2024-06-212024-06-210001613103mdt:A3.650SeniorNotesDue2029Member2024-06-212024-06-210001613103mdt:A1.625SeniorNotesDue2031Member2024-06-212024-06-210001613103mdt:A1.000SeniorNotesDue2031Member2024-06-212024-06-210001613103mdt:A3.125SeniorNotesDue2031Member2024-06-212024-06-210001613103mdt:A0.750SeniorNotesDue2032Member2024-06-212024-06-210001613103mdt:A3.375SeniorNotesDue2034Member2024-06-212024-06-210001613103mdt:A3.875SeniorNotesDue2036Member2024-06-212024-06-210001613103mdt:A2.250SeniorNotesDue2039Member2024-06-212024-06-210001613103mdt:A1.500SeniorNotesDue2039Member2024-06-212024-06-210001613103mdt:A1.375SeniorNotesDue2040Member2024-06-212024-06-210001613103mdt:A4.150SeniorNotesDue2043Member2024-06-212024-06-210001613103mdt:A1.750SeniorNotesDue2049Member2024-06-212024-06-210001613103mdt:A1.625SeniorNotesDue2050Member2024-06-212024-06-210001613103mdt:A4.150SeniorNotesDue2053Member2024-06-212024-06-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K/A
Amendment No. 1
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 21, 2024
 _____________________________ 
Medtronic plc
(Exact name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

Building Two
Parkmore Business Park West
Galway, Ireland
(Address of principal executive offices) (Zip Code)
+353 1 438-1700
(Registrant’s telephone number, including area code)
20 On Hatch, Lower Hatch Street, Dublin 2, Ireland
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))












Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange
0.250% Senior Notes due 2025MDT/25New York Stock Exchange
0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange
2.625% Senior Notes due 2025MDT/25BNew York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
0.375% Senior Notes due 2028MDT/28New York Stock Exchange
3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange
3.650% Senior Notes due 2029MDT/29New York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange
3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange
0.750% Senior Notes due 2032MDT/32New York Stock Exchange
3.375% Senior Notes due 2034MDT/34New York Stock Exchange
3.875% Senior Notes due 2036MDT/36New York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange
4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange
1.750% Senior Notes due 2049MDT/49New York Stock Exchange
1.625% Senior Notes due 2050MDT/50New York Stock Exchange
4.150% Senior Notes due 2053MDT/53New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Explanatory Note
This Amendment No. 1 on Form 8-K/A (the “Form 8-K/A”) is being filed to supplement the disclosure under Item 5.02 of the Current Report on Form 8-K filed by Medtronic plc (the “Company”) with the Securities and Exchange Commission on June 26, 2024 (the “Original Report”). The Original Report confirmed that Gary Corona had been appointed as interim Chief Financial Officer of the Company effective as of August 3, 2024. On August 15, 2024 the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) approved certain modifications to Mr. Corona’s compensation arrangements in connection with his appointment as interim Chief Financial Officer. The Company hereby amends the Original Report to include information on Mr. Corona’s compensation. Other than providing the additional information in Item 5.02 below, no other disclosure in the Original Report is amended by this Form 8-K/A.
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In connection with the previously announced appointment of Gary Corona as the Company’s interim Chief Financial Officer, the Compensation Committee approved the following compensatory arrangement for Mr. Corona on August 15, 2024: (i) a bi‑weekly cash stipend in the amount of $12,500, effective as of August 3, 2024 and (ii) an equity grant of 8,966 time‑based restricted stock units (“RSUs”) of the Company’s stock. The RSUs will vest over two years, with fifty percent (50%) of the total number of shares vesting annually on each of the first and second anniversaries of the date of grant. The Compensation Committee maintained Mr. Corona’s annual base salary of $500,000, target bonus equal to 70% of annual base salary, and long-term incentive grant of $1 million granted on July 29, 2024.







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   Medtronic plc
  By 
/s/ Ivan K. Fong
Date: August 16, 2024   
Ivan K. Fong
   Executive Vice President, General Counsel and Secretary





 EX-101.SCH 2 mdt-20240621.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 mdt-20240621_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 mdt-20240621_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Domain] Class of Stock [Domain] Class of Stock [Axis] Class of Stock [Axis] 1.125% Senior Notes due 2027 1.125% Senior Notes due 2027 [Member] 1.125% Senior Notes due 2027 Entity Address, City or Town Entity Address, City or Town Cover page. Cover [Abstract] 0.750% Senior Notes due 2032 0.750% Senior Notes due 2032 [Member] 0.750% Senior Notes due 2032 4.150% Senior Notes due 2043 4.150% Senior Notes due 2043 [Member] 4.150% Senior Notes due 2043 Ordinary shares, par value $0.0001 per share Common Stock [Member] Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Trading Symbol Trading Symbol Pre-commencement Tender Offer Pre-commencement Tender Offer 3.875% Senior Notes due 2036 3.875% Senior Notes due 2036 [Member] 3.875% Senior Notes due 2036 Entity Emerging Growth Company Entity Emerging Growth Company 0.375% Senior Notes due 2028 0.375% Senior Notes due 2028 [Member] 0.375% Senior Notes due 2028 Entity Address, Country Entity Address, Country Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number 1.750% Senior Notes due 2049 1.750% Senior Notes due 2049 [Member] 1.750% Senior Notes due 2049 Amendment Description Amendment Description Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, Address Line Two Entity Address, Address Line Two 3.650% Senior Notes due 2029 3.650% Senior Notes due 2029 [Member] 3.650% Senior Notes due 2029 Title of 12(b) Security Title of 12(b) Security Document Period End Date Document Period End Date 1.625% Senior Notes due 2031 1.625% Senior Notes due 2031 [Member] 1.625% Senior Notes due 2031 Entity Information [Line Items] Entity Information [Line Items] Document Type Document Type Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entities [Table] Entities [Table] 1.375% Senior Notes due 2040 1.375% Senior Notes due 2040 [Member] 1.375% Senior Notes due 2040 Security Exchange Name Security Exchange Name 1.625% Senior Notes due 2050 1.625% Senior Notes due 2050 [Member] 1.625% Senior Notes due 2050 Soliciting Material Soliciting Material City Area Code City Area Code Entity Tax Identification Number Entity Tax Identification Number Address Type [Domain] Address Type [Domain] 2.625% Senior Notes due 2025 2.625% Senior Notes due 2025 [Member] 2.625% Senior Notes due 2025 3.000% Senior Notes due 2028 3.000% Senior Notes due 2028 [Member] 3.000% Senior Notes due 2028 1.500% Senior Notes due 2039 1.500% Senior Notes due 2039 [Member] 1.500% Senior Notes due 2039 1.000% Senior Notes due 2031 1.000% Senior Notes due 2031 [Member] 1.000% Senior Notes due 2031 3.375% Senior Notes due 2034 3.375% Senior Notes due 2034 [Member] 3.375% Senior Notes due 2034 0.000% Senior Notes due 2025 0.000% Senior Notes due 2025 [Member] 0.000% Senior Notes due 2025 4.150% Senior Notes due 2053 4.150% Senior Notes due 2053 [Member] 4.150% Senior Notes due 2053 0.250% Senior Notes due 2025 0.250% Senior Notes due 2025 [Member] 0.250% Senior Notes due 2025 Written Communications Written Communications 2.250% Senior Notes due 2039 2.250% Senior Notes due 2039 [Member] 2.250% Senior Notes due 2039 Local Phone Number Local Phone Number Country Region Country Region Former Address Former Address [Member] 3.125% Senior Notes due 2031 3.125% Senior Notes due 2031 [Member] 3.125% Senior Notes due 2031 EX-101.PRE 5 mdt-20240621_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Cover
Jun. 21, 2024
Entity Information [Line Items]  
Document Type 8-K/A
Document Period End Date Jun. 21, 2024
Entity Incorporation, State or Country Code L2
Entity File Number 1-36820
Entity Tax Identification Number 98-1183488
Entity Address, Address Line One Building Two
Entity Address, City or Town Galway,
Entity Address, Country IE
Country Region 353
City Area Code 1
Local Phone Number 438-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001613103
Entity Registrant Name Medtronic plc
Entity Address, Postal Zip Code H91 VY19
Amendment Flag true
Amendment Description Updating prior disclosure as a result of compensation committee approval of new compensation arrangements for our interim CFO.
Entity Address, Address Line Two Parkmore Business Park West
Former Address  
Entity Information [Line Items]  
Entity Address, Address Line One 20 On Hatch
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Entity Address, Postal Zip Code D02 XH02
Entity Address, Address Line Two Lower Hatch Street
Ordinary shares, par value $0.0001 per share  
Entity Information [Line Items]  
Title of 12(b) Security Ordinary shares, par value $0.0001 per share
Trading Symbol MDT
Security Exchange Name NYSE
0.250% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.250% Senior Notes due 2025
Trading Symbol MDT/25
Security Exchange Name NYSE
0.000% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2025
Trading Symbol MDT/25A
Security Exchange Name NYSE
2.625% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 2.625% Senior Notes due 2025
Trading Symbol MDT/25B
Security Exchange Name NYSE
1.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.125% Senior Notes due 2027
Trading Symbol MDT/27
Security Exchange Name NYSE
0.375% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2028
Trading Symbol MDT/28
Security Exchange Name NYSE
3.000% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 3.000% Senior Notes due 2028
Trading Symbol MDT/28A
Security Exchange Name NYSE
3.650% Senior Notes due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 3.650% Senior Notes due 2029
Trading Symbol MDT/29
Security Exchange Name NYSE
1.625% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2031
Trading Symbol MDT/31
Security Exchange Name NYSE
1.000% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.000% Senior Notes due 2031
Trading Symbol MDT/31A
Security Exchange Name NYSE
3.125% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 3.125% Senior Notes due 2031
Trading Symbol MDT/31B
Security Exchange Name NYSE
0.750% Senior Notes due 2032  
Entity Information [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2032
Trading Symbol MDT/32
Security Exchange Name NYSE
3.375% Senior Notes due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 3.375% Senior Notes due 2034
Trading Symbol MDT/34
Security Exchange Name NYSE
3.875% Senior Notes due 2036  
Entity Information [Line Items]  
Title of 12(b) Security 3.875% Senior Notes due 2036
Trading Symbol MDT/36
Security Exchange Name NYSE
2.250% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 2.250% Senior Notes due 2039
Trading Symbol MDT/39A
Security Exchange Name NYSE
1.500% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 1.500% Senior Notes due 2039
Trading Symbol MDT/39B
Security Exchange Name NYSE
1.375% Senior Notes due 2040  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Senior Notes due 2040
Trading Symbol MDT/40A
Security Exchange Name NYSE
4.150% Senior Notes due 2043  
Entity Information [Line Items]  
Title of 12(b) Security 4.150% Senior Notes due 2043
Trading Symbol MDT/43A
Security Exchange Name NYSE
1.750% Senior Notes due 2049  
Entity Information [Line Items]  
Title of 12(b) Security 1.750% Senior Notes due 2049
Trading Symbol MDT/49
Security Exchange Name NYSE
1.625% Senior Notes due 2050  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2050
Trading Symbol MDT/50
Security Exchange Name NYSE
4.150% Senior Notes due 2053  
Entity Information [Line Items]  
Title of 12(b) Security 4.150% Senior Notes due 2053
Trading Symbol MDT/53
Security Exchange Name NYSE
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 23 25 1 false 22 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.medtronic.com/role/Cover Cover Cover 1 false false All Reports Book All Reports mdt-20240621.htm mdt-20240621.xsd mdt-20240621_def.xml mdt-20240621_lab.xml mdt-20240621_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mdt-20240621.htm": { "nsprefix": "mdt", "nsuri": "http://www.medtronic.com/20240621", "dts": { "inline": { "local": [ "mdt-20240621.htm" ] }, "schema": { "local": [ "mdt-20240621.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "mdt-20240621_def.xml" ] }, "labelLink": { "local": [ "mdt-20240621_lab.xml" ] }, "presentationLink": { "local": [ "mdt-20240621_pre.xml" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 2, "axisCustom": 0, "memberStandard": 2, "memberCustom": 20, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2024": 5 }, "contextCount": 23, "entityCount": 1, "segmentCount": 22, "elementCount": 54, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 90 }, "report": { "R1": { "role": "http://www.medtronic.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mdt-20240621.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mdt-20240621.htm", "first": true, "unique": true } } }, "tag": { "mdt_A0.000SeniorNotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A0.000SeniorNotesDue2025Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "0.000% Senior Notes due 2025", "label": "0.000% Senior Notes due 2025 [Member]", "documentation": "0.000% Senior Notes due 2025" } } }, "auth_ref": [] }, "mdt_A0.250SeniorNotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A0.250SeniorNotesDue2025Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "0.250% Senior Notes due 2025", "label": "0.250% Senior Notes due 2025 [Member]", "documentation": "0.250% Senior Notes due 2025" } } }, "auth_ref": [] }, "mdt_A0.375SeniorNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A0.375SeniorNotesDue2028Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "0.375% Senior Notes due 2028", "label": "0.375% Senior Notes due 2028 [Member]", "documentation": "0.375% Senior Notes due 2028" } } }, "auth_ref": [] }, "mdt_A0.750SeniorNotesDue2032Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A0.750SeniorNotesDue2032Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "0.750% Senior Notes due 2032", "label": "0.750% Senior Notes due 2032 [Member]", "documentation": "0.750% Senior Notes due 2032" } } }, "auth_ref": [] }, "mdt_A1.000SeniorNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A1.000SeniorNotesDue2031Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.000% Senior Notes due 2031", "label": "1.000% Senior Notes due 2031 [Member]", "documentation": "1.000% Senior Notes due 2031" } } }, "auth_ref": [] }, "mdt_A1.125SeniorNotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A1.125SeniorNotesDue2027Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.125% Senior Notes due 2027", "label": "1.125% Senior Notes due 2027 [Member]", "documentation": "1.125% Senior Notes due 2027" } } }, "auth_ref": [] }, "mdt_A1.375SeniorNotesDue2040Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A1.375SeniorNotesDue2040Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.375% Senior Notes due 2040", "label": "1.375% Senior Notes due 2040 [Member]", "documentation": "1.375% Senior Notes due 2040" } } }, "auth_ref": [] }, "mdt_A1.500SeniorNotesDue2039Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A1.500SeniorNotesDue2039Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.500% Senior Notes due 2039", "label": "1.500% Senior Notes due 2039 [Member]", "documentation": "1.500% Senior Notes due 2039" } } }, "auth_ref": [] }, "mdt_A1.625SeniorNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A1.625SeniorNotesDue2031Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.625% Senior Notes due 2031", "label": "1.625% Senior Notes due 2031 [Member]", "documentation": "1.625% Senior Notes due 2031" } } }, "auth_ref": [] }, "mdt_A1.625SeniorNotesDue2050Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A1.625SeniorNotesDue2050Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.625% Senior Notes due 2050", "label": "1.625% Senior Notes due 2050 [Member]", "documentation": "1.625% Senior Notes due 2050" } } }, "auth_ref": [] }, "mdt_A1.750SeniorNotesDue2049Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A1.750SeniorNotesDue2049Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.750% Senior Notes due 2049", "label": "1.750% Senior Notes due 2049 [Member]", "documentation": "1.750% Senior Notes due 2049" } } }, "auth_ref": [] }, "mdt_A2.250SeniorNotesDue2039Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A2.250SeniorNotesDue2039Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "2.250% Senior Notes due 2039", "label": "2.250% Senior Notes due 2039 [Member]", "documentation": "2.250% Senior Notes due 2039" } } }, "auth_ref": [] }, "mdt_A2.625SeniorNotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A2.625SeniorNotesDue2025Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "2.625% Senior Notes due 2025", "label": "2.625% Senior Notes due 2025 [Member]", "documentation": "2.625% Senior Notes due 2025" } } }, "auth_ref": [] }, "mdt_A3.000SeniorNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A3.000SeniorNotesDue2028Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "3.000% Senior Notes due 2028", "label": "3.000% Senior Notes due 2028 [Member]", "documentation": "3.000% Senior Notes due 2028" } } }, "auth_ref": [] }, "mdt_A3.125SeniorNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A3.125SeniorNotesDue2031Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "3.125% Senior Notes due 2031", "label": "3.125% Senior Notes due 2031 [Member]", "documentation": "3.125% Senior Notes due 2031" } } }, "auth_ref": [] }, "mdt_A3.375SeniorNotesDue2034Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A3.375SeniorNotesDue2034Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "3.375% Senior Notes due 2034", "label": "3.375% Senior Notes due 2034 [Member]", "documentation": "3.375% Senior Notes due 2034" } } }, "auth_ref": [] }, "mdt_A3.650SeniorNotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A3.650SeniorNotesDue2029Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "3.650% Senior Notes due 2029", "label": "3.650% Senior Notes due 2029 [Member]", "documentation": "3.650% Senior Notes due 2029" } } }, "auth_ref": [] }, "mdt_A3.875SeniorNotesDue2036Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A3.875SeniorNotesDue2036Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "3.875% Senior Notes due 2036", "label": "3.875% Senior Notes due 2036 [Member]", "documentation": "3.875% Senior Notes due 2036" } } }, "auth_ref": [] }, "mdt_A4.150SeniorNotesDue2043Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A4.150SeniorNotesDue2043Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "4.150% Senior Notes due 2043", "label": "4.150% Senior Notes due 2043 [Member]", "documentation": "4.150% Senior Notes due 2043" } } }, "auth_ref": [] }, "mdt_A4.150SeniorNotesDue2053Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20240621", "localname": "A4.150SeniorNotesDue2053Member", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "4.150% Senior Notes due 2053", "label": "4.150% Senior Notes due 2053 [Member]", "documentation": "4.150% Senior Notes due 2053" } } }, "auth_ref": [] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AddressTypeDomain", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Address Type [Domain]", "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Description", "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, par value $0.0001 per share", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Country Region", "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitiesTable", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Addresses, Address Type [Axis]", "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationLineItems", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_FormerAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "FormerAddressMember", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Former Address", "label": "Former Address [Member]", "documentation": "Former address for entity" } } }, "auth_ref": [ "r6", "r7" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.medtronic.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r8" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "249", "Section": "308", "Subsection": "a" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Number": "249", "Section": "308" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001613103-24-000133-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001613103-24-000133-xbrl.zip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end XML 17 mdt-20240621_htm.xml IDEA: XBRL DOCUMENT 0001613103 2024-06-21 2024-06-21 0001613103 dei:FormerAddressMember 2024-06-21 2024-06-21 0001613103 us-gaap:CommonStockMember 2024-06-21 2024-06-21 0001613103 mdt:A0.250SeniorNotesDue2025Member 2024-06-21 2024-06-21 0001613103 mdt:A0.000SeniorNotesDue2025Member 2024-06-21 2024-06-21 0001613103 mdt:A2.625SeniorNotesDue2025Member 2024-06-21 2024-06-21 0001613103 mdt:A1.125SeniorNotesDue2027Member 2024-06-21 2024-06-21 0001613103 mdt:A0.375SeniorNotesDue2028Member 2024-06-21 2024-06-21 0001613103 mdt:A3.000SeniorNotesDue2028Member 2024-06-21 2024-06-21 0001613103 mdt:A3.650SeniorNotesDue2029Member 2024-06-21 2024-06-21 0001613103 mdt:A1.625SeniorNotesDue2031Member 2024-06-21 2024-06-21 0001613103 mdt:A1.000SeniorNotesDue2031Member 2024-06-21 2024-06-21 0001613103 mdt:A3.125SeniorNotesDue2031Member 2024-06-21 2024-06-21 0001613103 mdt:A0.750SeniorNotesDue2032Member 2024-06-21 2024-06-21 0001613103 mdt:A3.375SeniorNotesDue2034Member 2024-06-21 2024-06-21 0001613103 mdt:A3.875SeniorNotesDue2036Member 2024-06-21 2024-06-21 0001613103 mdt:A2.250SeniorNotesDue2039Member 2024-06-21 2024-06-21 0001613103 mdt:A1.500SeniorNotesDue2039Member 2024-06-21 2024-06-21 0001613103 mdt:A1.375SeniorNotesDue2040Member 2024-06-21 2024-06-21 0001613103 mdt:A4.150SeniorNotesDue2043Member 2024-06-21 2024-06-21 0001613103 mdt:A1.750SeniorNotesDue2049Member 2024-06-21 2024-06-21 0001613103 mdt:A1.625SeniorNotesDue2050Member 2024-06-21 2024-06-21 0001613103 mdt:A4.150SeniorNotesDue2053Member 2024-06-21 2024-06-21 0001613103 D02 XH02 true Updating prior disclosure as a result of compensation committee approval of new compensation arrangements for our interim CFO. H91 VY19 8-K/A 2024-06-21 Medtronic plc L2 1-36820 98-1183488 Building Two Parkmore Business Park West Galway, IE 353 1 438-1700 20 On Hatch Lower Hatch Street Dublin 2 IE false false false false Ordinary shares, par value $0.0001 per share MDT NYSE 0.250% Senior Notes due 2025 MDT/25 NYSE 0.000% Senior Notes due 2025 MDT/25A NYSE 2.625% Senior Notes due 2025 MDT/25B NYSE 1.125% Senior Notes due 2027 MDT/27 NYSE 0.375% Senior Notes due 2028 MDT/28 NYSE 3.000% Senior Notes due 2028 MDT/28A NYSE 3.650% Senior Notes due 2029 MDT/29 NYSE 1.625% Senior Notes due 2031 MDT/31 NYSE 1.000% Senior Notes due 2031 MDT/31A NYSE 3.125% Senior Notes due 2031 MDT/31B NYSE 0.750% Senior Notes due 2032 MDT/32 NYSE 3.375% Senior Notes due 2034 MDT/34 NYSE 3.875% Senior Notes due 2036 MDT/36 NYSE 2.250% Senior Notes due 2039 MDT/39A NYSE 1.500% Senior Notes due 2039 MDT/39B NYSE 1.375% Senior Notes due 2040 MDT/40A NYSE 4.150% Senior Notes due 2043 MDT/43A NYSE 1.750% Senior Notes due 2049 MDT/49 NYSE 1.625% Senior Notes due 2050 MDT/50 NYSE 4.150% Senior Notes due 2053 MDT/53 NYSE false